Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Thoracic Surgery

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.athoracsur.2011.06.028PMID 21967819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Approaches for Preventing or Limiting Events in Diabetic Patients (Naples-Diabetes) Trial: A Randomized Comparison of 3 Drug-Eluting Stents in Diabetic Patients

  2011cited by this paper
• Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial

  2011cited by this paper
• Novel Approaches for Preventing or Limiting Events in Diabetic Patients (Naples-Diabetes) TrialClinical Perspective

  2011cited by this paper
• Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.

  2011cited by this paper
• Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.

  2010cited by this paper
• The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study.

  2010cited by this paper
• The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock.

  2010cited by this paper
• Diabetes does not affect long-term results after total arterial off-pump coronary revascularization.

  2010cited by this paper
• Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

  2009cited by this paper
• TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.

  2009cited by this paper
• Sirolimus eluting stent (Cypher™) in patients with diabetes mellitus: results from the German Cypher Stent Registry

  2008cited by this paper
• Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.

  2008cited by this paper
• Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery.

  2007cited by this paper
• Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.

  2007cited by this paper
• Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery

  2007cited by this paper
• The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.

  2006cited by this paper
• Metabolic syndrome negatively impacts early patency of saphenous vein grafts

  2006cited by this paper
• The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

  2005cited by this paper
• Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

  2005cited by this paper
• Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Predictors of 30-day hospital readmission after coronary artery bypass.

  2000cited by this paper
• Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement.

  1998cited by this paper
• Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

  1995cited by this paper

• The effect of HbA1c on coronary artery bypass grafting mortality and morbidity in concomitant diabetes mellitus and coronary artery disease

  2025cites this paper
• FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes.

  2025cites this paper
• Short- and Long-term Prognostic Impacts of Diabetes Mellitus in Patients Undergoing Off-pump Coronary Artery Bypass Grafting with Skeletonized Internal Thoracic Artery Graft

  2025cites this paper
• The effect of diabetes on mid-term survival of open heart surgery patients aged over 70 years

  2022cites this paper
• Percutaneous Coronary Intervention with Everolimus-Eluting Versus Sirolimus-Eluting Stents in Diabetic Patients Presented with Acute Coronary Syndromes: A Short-term Comparative Clinical Outcome Study

  2022cites this paper
• CABG versus PCI in the Treatment of Unprotected Left Main Disease in Diabetics: A Literature Review.

  2021cites this paper
• Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial).

  2021cites this paper
• Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study

  2020cites this paper
• Diabetes and periprocedural outcomes in patients treated with rotablation during percutaneous coronary interventions.

  2020cites this paper
• Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures

  2020cites this paper
• Diabetes and Cardiovascular Disease

  2019cites this paper
• Diabetes and Cardiovascular Disease

  2018cites this paper
• Revascularization Strategies in Multivessel Coronary Artery Disease

  2018cites this paper
• The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience

  2018cites this paper
• Impact of TCFA on Unanticipated Ischemic Events in Medically Treated Diabetes Mellitus: Insights From the PROSPECT Study.

  2017cites this paper
• Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?

  2017cites this paper
• Intracoronary Insights in Diabetes Mellitus

  2017cites this paper
• Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in Patients with Diabetes

  2017cites this paper
• Prognosis of diabetic coronary artery bypass graft surgery patients

  2017cites this paper
• Multivessel Revascularization in Shock and High-Risk Percutaneous Coronary Intervention.

  2017cites this paper
• Coronary Artery Disease and Type 2 Diabetes Mellitus.

  2017cites this paper
• Body Mass Index Is Associated With Differential Rates of Coronary Revascularization After Cardiac Catheterization.

  2017cites this paper
• Current Risk Scores for the Establishment of the Best Myocardial Revascularization Methods

  2016cites this paper
• Avaliação de desfechos após intervenção coronária percutânea com implante de stents farmacológicos em diabéticos multiarteriais: impacto incremental dos escores SYNTAX e SYNTAX residual em resultados clínicos de longo prazo

  2016cites this paper
• Outcome evaluation after percutaneous coronary intervention with drug-eluting stent implantation in multivessel diabetic patients: incremental impact of SYNTAX and residual SYNTAX scores on long-term clinical outcomes

  2016cites this paper
• Determining the Most Appropriate Mode of Coronary Artery Revascularisation in Patients With Diabetes.

  2016influential citation
• Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?

  2015cites this paper
• Revascularization in Patients with Diabetes: PCI or CABG or None at All

  2015cites this paper
• Outcomes of Primary Percutaneous Coronary Intervention for Patients with Previous Coronary Artery Bypass Grafting Presenting with STsegment Elevation Myocardial Infarction

  2015cites this paper
• Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression

  2015cites this paper
• Coronary artery bypass grafting in diabetics: A growing health care cost crisis.

  2015cites this paper
• Clinical Trials Versus Clinical Practice

  2015cites this paper
• Desfechos clínicos tardios de pacientes diabéticos tratados com stents farmacológicos eluidores de sirolimus ou everolimus: uma análise do registro DESIRE

  2015cites this paper
• Background to the Discussion Paper: Proposed Recommendations for Myocardial Revascularisation.

  2015cites this paper
• Coronary artery bypass grafting versus drug‐eluting stents in patients with severe coronary artery disease and diabetes mellitus: Systematic review and meta‐analysis 冠状动脉旁路移植术与药物洗脱支架治疗严重冠心病合并糖尿病的患者：系统评估和meta分析

  2015cites this paper
• Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives.

  2015cites this paper
• Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis.

  2015cites this paper
• Late clinical outcomes of diabetic patients treated with sirolimus or everolimus drug-eluting stents: an analysis of the DESIRE registry

  2015cites this paper
• Proposed Recommendations for Myocardial Revascularisation.

  2015cites this paper
• Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Society for the Study of Diabetes

  2014cites this paper
• Long-Term Survival after CABG in Diabetics with Aggressive Risk Factor Management

  2014cites this paper
• Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease

  2014cites this paper
• Drug-eluting stents versus coronary artery bypass grafting in diabetic patients with multi-vessel disease: a meta-analysis.

  2014influential citation
• Clinical impact of second-generation everolimus-eluting stents compared with first-generation drug-eluting stents in diabetic patients undergoing multivessel percutaneous coronary intervention.

  2014cites this paper
• Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.

  2014cites this paper
• Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.

  2014cites this paper
• [Multidisciplinary management of patients with acute coronary syndrome and diabetes mellitus: from antithrombotic therapy to treatment of hyperglycemia].

  2014cites this paper
• Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis.

  2014cites this paper
• Everolimus-eluting versus sirolimus-eluting coronary stents in patients with and without diabetes mellitus.

  2014cites this paper
• Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.

  2014cites this paper
• Interventions for coronary artery disease (surgery vs angioplasty) in diabetic patients.

  2014cites this paper
• Outcomes of coronary artery interventions: Comparing coronary artery bypass surgery and percutaneous coronary intervention in patients with unprotected left main stenosis

  2014cites this paper
• Vascular Complications of Diabetes Mellitus

  2014cites this paper
• Coronary bypass for diabetic heart patients

  2014cites this paper
• A PATIENT WITH SEVERE HEART FAILURE, MULTIVESSEL CORONARY ARTERY DISEASE, AND DIABETES

  2014cites this paper
• РЕКОМЕНДАЦИИ ПО ДИАБЕТУ, ПРЕДИАБЕТУ И СЕРДЕЧНО-СОСУДИСТЫМ ЗАБОЛЕВАНИЯМ.

  2014cites this paper
• Society Guidelines Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease

  2014cites this paper
• Coronary Revascularization in Diabetic Patients

  2014cites this paper
• Coronary bypass for diabetic heart patients Review

  2014cites this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

  2014cites this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration

  2014cites this paper
• Cardiopatía diabética y cardiología intervencionista: ¿cómo se puede mejorar los resultados clínicos? Revascularización guiada por parámetros hemodinámicos (reserva de flujo fraccional)

  2013cites this paper
• Coronary artery revascularization in patients with diabetes mellitus.

  2013cites this paper
• Percutaneous Coronary Intervention as an Alternative to Coronary Artery Bypass Grafting in Patients with to Coronary Artery Bypass Grafting in Patients with to Coronary Artery Bypass Grafting in Patients with to Coronary Artery Bypass Grafting in Patients with

  2013cites this paper
• Rôle de la revascularisation coronarienne chez le patient diabétique avec maladie coronarienne stable

  2013cites this paper
• The adequacy of myocardial revascularization in patients with multivessel coronary artery disease.

  2013cites this paper
• Diabetes as an independent predictor of high atherosclerotic burden assessed by coronary computed tomography angiography: the coronary artery disease equivalent revisited

  2013cites this paper
• Optimal revascularization in diabetes after the FREEDOM trial: were the controversies finally settled?

  2013cites this paper
• Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.

  2013cites this paper
• [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].

  2013cites this paper
• Fünfjahres-Follow-up der Studie „Synergy between PCI with Taxus and Cardiac Surgery“

  2013cites this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

  2013cites this paper
• An Update on Drug-Eluting Stents

  2013cites this paper
• Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data

  2013cites this paper
• Diabetes and the Cardiovascular System

  2013cites this paper
• Current world literature.

  2013cites this paper
• Revascularization strategies in patients with Type 2 diabetes mellitus

  2013cites this paper
• Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.

  2013cites this paper
• The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI

  2013cites this paper
• Diabetic heart disease and interventional cardiology: how can clinical outcomes be improved? Revascularization guided by hemodynamic parameters (fractional flow reserve).

  2013influential citation
• Impact of left ventricular dysfunction on early and late outcomes in patients undergoing concomitant aortic valve replacement and coronary artery bypass graft surgery.

  2013cites this paper
• Percutaneous coronary intervention with drug-eluting stents or coronary artery bypass surgery in subjects with type 2 diabetes

  2013cites this paper
• Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus

  2013cites this paper
• Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes.

  2013cites this paper
• Coronary revascularization for patients with diabetes: updated data favor coronary artery bypass grafting.

  2013cites this paper
• Electrospun Rapamycin-Eluting Polyurethane Fibers for Vascular Grafts

  2013cites this paper
• Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

  2012cites this paper
• Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score.

  2012influential citation
• Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome

  2012cites this paper
• The Year in Review: Surgical Revascularization of Coronary Artery Disease—2011

  2012cites this paper
• Percutaneous Coronary Intervention in Patients with Diabetes and Multivessel or Left Main Disease – a Review

  2012cites this paper
• Surgical perspectives on the management of advanced stable coronary artery disease

  2012cites this paper
• Treatment strategies for women with coronary artery disease

  2012cites this paper
• 2011 Publications of the Baylor Health Care System Medical and Scientific Staff

  2012cites this paper
• Give me FREEDOM or...

  2012cites this paper
• Perioperative Antiplatelet Management in Patients with Coronary Artery Stenting

  2012cites this paper
• Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.

  2012cites this paper
• Coronary revascularization in diabetic patients

  2012cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper